FAST NEWS: Simcere Pharmaceutical Grants Overseas Rights for Drug Candidate
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced Thursday that it granted Almirall S.A. exclusive rights to develop and commercialize its autoimmune drug candidate SIM0278 outside of Greater China. Looking up: Simcere…
RELATED ARTICLES
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
-
Clinical trials come up short again for Alphamab Oncology
9966.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
Discover hidden China stock gems in our weekly newsletter